Definitive Healthcare (Definitive Healthcare) Cash Flow from Financing : $-39.3 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Definitive Healthcare Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, Definitive Healthcare paid $0.0 Mil more to buy back shares than it received from issuing new shares. It spent $3.4 Mil paying down its debt. It paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.0 Mil from paying cash dividends to shareholders. It spent $13.8 Mil on other financial activities. In all, Definitive Healthcare spent $17.2 Mil on financial activities for the three months ended in Mar. 2024.

Definitive Healthcare Cash Flow from Financing Historical Data

The historical data trend for Definitive Healthcare's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Definitive Healthcare Cash Flow from Financing Chart

Definitive Healthcare Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow from Financing

16.66

384.37

-26.70

-25.58

Definitive Healthcare Quarterly Data
	Jul19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow from Financing	Get a 7-Day Free Trial													-3.53	-5.63	-10.37	-6.06	-17.19

Definitive Healthcare Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Definitive Healthcare's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

	Cash Flow from Financing		(A: Dec. 2023 )
=	Issuance of Stock	+	Repurchase of Stock	+	Net Issuance of Debt	+	Net Issuance of Preferred Stock	+	Cash Flow for Dividends	+	Other Financing
=	0	+	0	+	-8.594	+	0	+	-12.282	+	-4.708
=	-25.6

Definitive Healthcare's Cash from Financing for the quarter that ended in Mar. 2024 is:

	Cash Flow from Financing		(Q: Mar. 2024 )
=	Issuance of Stock	+	Repurchase of Stock	+	Net Issuance of Debt	+	Net Issuance of Preferred Stock	+	Cash Flow for Dividends	+	Other Financing
=	0	+	0	+	-3.438	+	0	+	0	+	-13.756
=	-17.2

Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-39.3 Mil.

Definitive Healthcare (NAS:DH) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Definitive Healthcare's issuance of stock for the three months ended in Mar. 2024 was $0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Definitive Healthcare's repurchase of stock for the three months ended in Mar. 2024 was $0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Definitive Healthcare's net issuance of debt for the three months ended in Mar. 2024 was $-3.4 Mil. Definitive Healthcare spent $3.4 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Definitive Healthcare's net issuance of preferred for the three months ended in Mar. 2024 was $0.0 Mil. Definitive Healthcare paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Definitive Healthcare's cash flow for dividends for the three months ended in Mar. 2024 was $0.0 Mil. Definitive Healthcare received $0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Definitive Healthcare's other financing for the three months ended in Mar. 2024 was $-13.8 Mil. Definitive Healthcare spent $13.8 Mil on other financial activities.

Definitive Healthcare Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Definitive Healthcare's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Definitive Healthcare (Definitive Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Definitive Healthcare Corp (NAS:DH) » Definitions » Cash Flow from Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

492 Old Connecticut Path, Suite 401, Framingham, MA, USA, 01701

Website

https://www.definitivehc.com

Definitive Healthcare Corp is a leading provider of healthcare commercial intelligence. The company's solutions provide accurate and comprehensive information on healthcare providers and their activities to help customers optimize everything from product development to go-to-market planning and sales and marketing execution. Geographically, it derives a majority of its revenue from the United States.

Executives

Carrie Lazorchak	officer: Chief Revenue Officer	C/O DEFINITIVE HEALTHCARE CORP., 492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM MA 01701
Scott G Stephenson	director	C/O VERISK ANALYTICS, INC., 545 WASHINGTON BOULEVARD, JERSEY CITY NJ 07310-1686
Sea Vii Management, Llc	director, 10 percent owner	ONE INTERNATIONAL PLACE, SUITE 3520, BOSTON MA 02110
Advent International Gp, Llc	director, 10 percent owner	800 BOYLSTON STREET SUITE 3300, BOSTON MA 02199
Spectrum Vii Investment Managers' Fund, L.p.	director, 10 percent owner	ONE INTERNATIONAL PLACE, 35TH FLOOR, BOSTON MA 02110
Jason Ronald Krantz	director, 10 percent owner, officer: Chief Executive Officer	C/O DEFINITIVE HEALTHCARE, LLC, 550 COCHITUATE ROAD, FRAMINGHAM MA 01701
Jonathan Maack	officer: President	C/O DEFINITIVE HEALTHCARE CORP., 550 COCHITUATE RD, FRAMINGHAM MA 01701
Sastry Chilukuri	director	5 BUDDY LANE, MORRISTOWN NJ 07960
David Randall Winn	director	7900 GLADES ROAD, SUITE 540, BOCA RATON FL 33434
Jeffrey Charles Haywood	director, 10 percent owner	C/O DEFINITIVE HEALTHCARE, LLC, 550 COCHITUATE ROAD, FRAMINGHAM MA 01701
Richard Douglas Booth	officer: Chief Financial Officer	200 CLARENDON STREET, T-9, BOSTON MA 02116
Kathleen A Winters	director	101 COLUMBIA ROAD, MORRISTOWN NJ 07960
Spectrum Vii Co-investment Fund, L.p.	director, 10 percent owner	ONE INTERNATIONAL PLACE, SUITE 3520, BOSTON MA 02110
Advent Global Technology-c Limited Partnership	director, 10 percent owner	PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON MA 02199-8069
Advent Global Technology-d Limited Partnership	director, 10 percent owner	PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON MA 02199-8069